Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Abiomed Inc.

    NASDAQ: ABMD · Real-Time Price · USD
    381.02
    0.00 (0.00%)
    At close: Dec 21, 2022, 10:00 PM

    Abiomed Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
    Revenue
    		 1.07B 1.06B 1.03B 1B 973.63M 935.26M 847.52M 812.93M 802.86M 798.07M
    Cost of Revenue
    		 200.59M 195.6M 188.16M 182.78M 176.26M 171.11M 161.91M 155.2M 154.08M 150.21M
    Gross Profit
    		 873.51M 860.72M 843.6M 820.37M 797.37M 764.14M 685.62M 657.74M 648.77M 647.85M
    Operating Income
    		 253.61M 256.06M 140.72M 138.52M 145.31M 146.21M 229.56M 224.81M 223.71M 222.56M
    Interest Income
    		 94.24M 13.53M 9.76M n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 341.16M 269.73M 190.56M 189.29M 212.15M 217.79M 288.22M 254.04M 270.32M 214.76M
    Net Income
    		 266.76M 217.58M 136.5M 133.04M 149.15M 154.41M 225.53M 200.47M 207.82M 158.67M
    Selling & General & Admin
    		 452.18M 438M 423.49M 414.25M 392.83M 369.22M 334.18M 317.7M 317.18M 323.97M
    Research & Development
    		 167.22M 166.17M 163.4M 151.61M 143.74M 133.23M 121.88M 115.23M 107.88M 101.33M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 619.4M 604.17M 586.89M 565.86M 536.58M 502.45M 456.06M 432.93M 425.06M 425.29M
    Interest Expense
    		 94.24M 13.53M 9.76M n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 819.99M 799.77M 775.05M 748.64M 712.84M 673.56M 617.97M 588.13M 579.14M 575.51M
    Income Tax Expense
    		 74.4M 52.15M 54.05M 56.26M 63M 63.38M 62.7M 53.57M 62.5M 56.09M
    Shares Outstanding (Basic)
    		 45.37M 45.58M 45.52M 45.51M 45.44M 45.31M 45.25M 45.2M 45.1M 45.01M
    Shares Outstanding (Diluted)
    		 45.71M 45.92M 45.95M 45.92M 45.89M 45.31M 45.78M 45.71M 45.66M 45.55M
    EPS (Basic)
    		 5.88 4.79 3.00 2.93 3.29 3.42 5.00 4.45 4.61 3.52
    EPS (Diluted)
    		 5.82 4.74 2.96 2.89 3.24 3.36 4.93 4.39 4.55 3.47
    EBITDA
    		 284.19M 285.9M 400.78M 394.15M 398.59M 397.34M 246.94M 239.31M 235.82M 232.59M
    EBIT
    		 442.09M 222.68M 149.09M 64.57M n/a n/a n/a n/a n/a n/a
    Depreciation & Amortization
    		 27.56M 27.8M 28.09M 27.63M 26.83M 25.52M 24.1M 23.27M 22.52M 21.55M

    Add to Watchlist